This brand name is authorized in Ecuador, Israel, Poland, Singapore, Spain, Turkey.
The drug BILAXTEN contains one active pharmaceutical ingredient (API):
1
|
UNII
PA1123N395 - BILASTINE
|
|
Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral Η1 receptor antagonist affinity and no affinity for muscarinic receptors. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R06AX29 | Bilastine | R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 361570812, 5492-MEE-0920, 6244-MEE-0521 |
| ES | Centro de información online de medicamentos de la AEMPS | 3400949914012, 5341508, 73027, 82581, 82582 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 8134 |
| PL | Rejestru Produktów Leczniczych | 100239991, 100355912, 100355929 |
| SG | Health Sciences Authority | 14661P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699832010039, 8699832010046, 8699832010053, 8699832010060, 8699832010077 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.